Kimia Farma’s Loss Due to Expired Vaccines
Monday, October 16, 2023
Kimia Farma and the holding of state-owned pharmaceutical companies have an excess stock of vaccines that are nearing their expiration date. The state could suffer losses.
KIMIA Farma is enjoying a good time in business. In the first semester of 2023, the state-owned pharmaceutical company made an operating profit of Rp236.29 billion (around US$15.7 million). This achievement stands in contrast to the situation in the first semester of last year, when Kimia Farma suffered an operational loss of Rp15.67 billion (US$1 million). Kimia Farma Chief Executive Officer (CEO) David Utama said that the company could rec
...
Subscribe to continue reading.
We craft news with stories.
For the benefits of subscribing to Digital Tempo, See More